Common Contracts
4 similar Development and License Agreement contracts by Eagle Pharmaceuticals, Inc.
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 20th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Development and License Agreement (“AGREEMENT”) is made and entered into September 24, 2007 (the “EFFECTIVE DATE”) by and between SciDose, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“SCIDOSE”), and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). SCIDOSE and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 20th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Development and License Agreement (“AGREEMENT”) is made and entered into June 12, 2007 (the “EFFECTIVE DATE”) by and between SciDose, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“SCIDOSE”); and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). SCIDOSE and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • December 17th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Development and License Agreement (“AGREEMENT”) is made and entered into June 12, 2007 (the “EFFECTIVE DATE”) by and between SciDose, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“SCIDOSE”); and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). SCIDOSE and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 25th, 2013 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Development and License Agreement (“AGREEMENT”) is made and entered into September 24, 2007 (the “EFFECTIVE DATE”) by and between SciDose, LLC, having its principal place of business at 123 Blackberry Lane, Amherst, MA 01002 (“SCIDOSE”), and Eagle Pharmaceutical, Inc. having its principal place of business at 470 Chestnut Ridge Road, Woodcliff Lake, NJ 07677 (“EAGLE”). SCIDOSE and EAGLE may be referred to herein individually as a “PARTY” and collectively as the “PARTIES.”
